Opella reaches study milestone for Cialis. Paris, January 21, 2025. Opella, Sanofi's Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lif ...

or if allergic to Cialis or Adcirca (tadalafil), or any of its ingredients. Anyone who experiences any symptoms of an allergic reaction, such as rash, hives, swelling of the lips, tongue or throat, or ...

or if allergic to Cialis or Adcirca (tadalafil), or any of its ingredients. Anyone who experiences any symptoms of an allergic reaction, such as rash, hives, swelling of the lips, tongue or throat, or ...

Cialis (tadalafil) in the US is currently only available with a prescription. Cialis is a tablet taken to treat erectile dysfunction (ED), the signs and symptoms of benign prostatic hyperplasia ...

Cost: Roman offers both brand-name Cialis and generic Cialis (tadalafil) that you can take as needed or on a daily basis at a lower dose. Here’s a breakdown of what you can expect to pay for ...

Few men use the most effective erection drugs because they must be self-injected into the penis. Few men are willing, but ...

Background This multicenter, randomized, double-blind, double-dummy, placebo-controlled trial primarily evaluated the efficacy of tadalafil once-daily (OaD) or on-demand ("pro-re-nata"; PRN ...

The trial is aimed at transitioning Cialis (tadalafil) from a prescription-only medication to an over-the-counter option. With this decision, the actual use trial can now proceed, marking Cialis ...

Sanofi’s (NASDAQ:SNY) consumer healthcare unit Opella announced Tuesday that the U.S. FDA has lifted a clinical hold on a trial designed to test an over-the-counter version of its erectile dysfunction ...